Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 10 de 10
2.
Article Ru | MEDLINE | ID: mdl-20737682

AIM: To perform preclinical study of subunit monovalent adsorbed inactivated influenza vaccine "PANDEFLU" [strains A/California/7/2009 (HIN1)v]. MATERIALS AND METHODS: Preclinical study of acute toxicity on experimental animals (assessment of vaccine's toxic effects on organs and body systems; pathomorphologic study of organs and tissues after administration of the vaccine; assessment of its influence on hematologic indicators). RESULTS: It was shown that administration of the vaccine did not lead to death of animals as well as to decrease of body mass or development of pathologic, focal sclerotic changes in parenchymal cells and visceral stroma; the vaccine did not negatively change hematologic and biochemical indicators of blood. Results of necropsy and histological study after acute administration of the vaccine in standard dose did not lead to irritation, inflammation or destruction of tissues in the place of inoculation. The vaccine was apyrogenic and did not have local irritating and allergenic effects. Status of animals after acute inoculation of the vaccine demonstrated its good tolerability and safety in doses exceeding standard human doses more than tenfold. CONCLUSION. Performed research demonstrated absence of contraindications for conduction of clinical trials of "PANDEFLU" vaccine on limited contingent of volunteers.


Influenza A Virus, H1N1 Subtype/immunology , Influenza Vaccines/adverse effects , Influenza, Human/prevention & control , Animals , Cricetinae , Drug Evaluation, Preclinical , Female , Humans , Influenza Vaccines/administration & dosage , Influenza Vaccines/immunology , Male , Mice , Vaccines, Inactivated/administration & dosage , Vaccines, Inactivated/adverse effects , Vaccines, Inactivated/immunology , Vaccines, Subunit/administration & dosage , Vaccines, Subunit/adverse effects , Vaccines, Subunit/immunology
3.
Article Ru | MEDLINE | ID: mdl-20468097

AIM: To perform preclinical assessment of new live monovalent vaccine Influvir against pandemic influenza virus A/H1N1 [strainA/17/California/2009/38 (H1N1)]. MATERIALS AND METHODS: Preclinical studies of acute toxicity and effect of Influvir vaccine on systems and organs of laboratory animals (rats and outbred white mice) was performed according to modern requirements of Institute of Toxicology. RESULTS: According to results of toxicometry and necroscopy, live monovalent influenza vaccine Influvir during intransal application was safe and had good tolerability during 14 days of observation for experimental animals after acute application. Performed preclinical studies allow to label the studied vaccine as class V virtually nontoxic drugs. CONCLUSION: According to results of preclinical studies, clinical trials of live monovalent intranasal influenza vaccine Influvir can be permitted.


Influenza A Virus, H1N1 Subtype/immunology , Influenza Vaccines/adverse effects , Influenza, Human/prevention & control , Administration, Intranasal , Animals , Drug Evaluation, Preclinical , Humans , Influenza Vaccines/administration & dosage , Influenza Vaccines/immunology , Mice , Rats , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/adverse effects , Vaccines, Attenuated/immunology
9.
Ross Fiziol Zh Im I M Sechenova ; 86(11): 1449-57, 2000 Nov.
Article Ru | MEDLINE | ID: mdl-11195212

Biochemical events of the rat hepatocytes cytolysis and deterioration of their synthetic activity and detoxification ability, as well as morphological events of lipid degeneration after acute poisoning with dichloretane and CCl4, were significantly reduced by effects of transcranial stimulation (TES). Blockade of the TES effects with naloxone revealed its endorphinergic nature. Combined effects of the TES and Essenciale preparation were lower than separate those of these agents. The TES effects were clinically corroborated in treatment of toxic hepatitis.


Brain/metabolism , Chemical and Drug Induced Liver Injury/metabolism , Endorphins/metabolism , Hepatocytes/metabolism , Animals , Carbon Tetrachloride Poisoning/metabolism , Carbon Tetrachloride Poisoning/pathology , Carbon Tetrachloride Poisoning/physiopathology , Chemical and Drug Induced Liver Injury/pathology , Chemical and Drug Induced Liver Injury/physiopathology , Electric Stimulation , Ethylene Dichlorides , Fatty Liver/pathology , Hepatocytes/pathology , Liver Function Tests , Male , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Phosphatidylcholines/pharmacology , Protective Agents/pharmacology , Rats , Rats, Wistar
10.
Farmakol Toksikol ; 50(2): 105-6, 1987.
Article Ru | MEDLINE | ID: mdl-3582625

Acute oral chlorophos poisoning of laboratory animals was shown to result in a decrease of the pulmonary surfactant system according to the severity of intoxication. Alupent in combination with atropine and dipyroxime prevented the disturbances of the system.


Metaproterenol/therapeutic use , Pulmonary Surfactants/antagonists & inhibitors , Trichlorfon/poisoning , Animals , Atropine/therapeutic use , Cats , Drug Evaluation, Preclinical , Drug Therapy, Combination , Female , Male , Mice , Time Factors , Trimedoxime/therapeutic use
...